The largest database of trusted experimental protocols

6 protocols using phi29 dna polymerase reaction buffer

1

Plasmodium DNA Enrichment via SWGA

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA extracts which had a qPCR CT value < 30 were tested using the Qubit for DNA concentration. Using this CT threshold, n = 145 samples were selected for further analysis. DNA concentration in the extracted dried blood spot samples was very low, of the range 0.011 ng/μl to 0.268 ng/μl. Selective whole genome amplification (SWGA) was used to amplify the Plasmodium DNA prior to sequencing, using a protocol adapted from Oyola et al.7 (link). Each SWGA reaction used 30 µl of extracted DNA, which was combined with 5 µl of phi29 DNA Polymerase Reaction Buffer (New England Biolabs), 0.5 µl of Recombinant Albumin (New England Biolabs), 0.5 µl of SWGA primers (250 mM) (Roche), 5 µl dNTPs (New England Biolabs) and 6 µl of water, to a total volume of 50 µl per reaction. SWGA reactions were then run in a thermocycler using the following programme steps: 35 °C for 5 min, 34 °C for 10 min, 33 °C for 15 min, 32 °C for 20 min, 31 °C for 25 min, 30 °C for 16 h, 65 °C for 10 min, and held at 4 °C. SWGA reactions increased the DNA concentration of samples to > 300 ng DNA in of the 48 of the 145 (33.1%) samples amplified.
+ Open protocol
+ Expand
2

Real-Time MDA of Tumor Cell DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA extracted from the GM12878 cell line was used as the template for real-time MDA, and the amount of template was controlled by adding a diluted DNA solution. The MDA system contained 1× phi29 DNA polymerase reaction buffer (New England Biolabs, USA), 50 μM random hexamer primer (Sangon, China), 4 mM dNTP, 1.5 U μl−1 phi29 DNA polymerase (New England Biolabs, USA), 0–4× EVAgreen dye (Biotium, USA) and 1× ROX dye (Takara, Japan). The reaction was carried out under 30 °C and the polymerase was inactivated with 65 °C after amplification using a real time thermal cycler (ABI 7500, Life Technologies, USA). Fluorescence intensity was detected and recorded every 9 min. The threshold was defined in different values, as described in the results section. Plots and fitting curves were generated using Origin Pro 2017.
Genomic DNA extracted from 3 different tumor cell lines (U937, A375 and ZR-75) was adjusted to 125 pg μl−1 and then diluted to 1/5 sequentially (5 times) with water. The samples of different DNA concentrations were then amplified via real-time MDA. The threshold time was measured and the dilution time was calculated accordingly.
+ Open protocol
+ Expand
3

Circular DNA Amplification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Circular ligation of pooled (by mass) DNA was performed in 3 ml reaction volume with T4 DNA ligase (M0202, New England Biolabs, Ipswich, MA, USA) according to manufacturer’s protocol. The mixture was incubated at 16 °C for 6 h before heat inactivation of T4 DNA ligase at 65 °C for 10 min. Ligated products were purified and concentrated using AMPure XP beads. Plasmid-Safe ATP-Dependent DNase (E3101, Epicentre, Madison, WI, USA) digest was performed according to manufacturer’s protocol at 37 °C for 1 h to remove non-circularized products. DNase was then heat inactivated at 70 °C for 30 min. Products were purified and concentrated using AMPure XP beads. The circular DNA template molecules were added to phi29 DNA polymerase reaction buffer (B0269, New England Biolabs) with 0.25 μg/μl BSA, 5 μM exo-resistant random primers (S0181, Thermo Fisher Scientific), 0.25 mM dNTP (N0447, New England Biolabs) and 10 U phi29 polymerase (M0269, New England Biolabs) in a total volume of 20 μl. The conditions for RCA were set up as follows: 95 °C for 3 min, 30 °C (ramp rate of 0.1 °C/s) for 6 h and 65 °C for 10 min. The time taken for amplification was optimized to yield substantial RCA products, while minimizing the possibility of sequences produced by unspecific priming of random primers. RCA products were finally purified with 0.45× volume of AMPure XP beads.
+ Open protocol
+ Expand
4

Synthesis of Labeled Single-Stranded DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
PAGE-purified oligos were purchased from IDT. ssDNA circles were prepared by annealing 5 μM phosphorylated template oligo (/5Phos/AG GAG AAA AAG AAA AAA AGA AAA GAA GG) and 4.5 μM biotinylated primer oligo (5/Biosg/TC TCC TCC TTC T) in 1× T4 ligase reaction buffer (NEB B0202S).31 (link),32 (link) Oligos were heated to 75 °C for 5 min and cooled to 4 °C at a rate of −1 °C min−1. Annealed circles were ligated with the addition of 1 μL of T4 DNA ligase (NEB M0202S) at room temperature for ~5 h. Ligated circles can be stored at 4 °C for up to 1 month. Low-complexity ssDNA was synthesized in 1× phi29 DNA polymerase reaction buffer (NEB M0269S), 500 μM dCTP and dTTP (NEB N0446S), 0.2 mg mL−1 BSA (NEB B9000S), 10 nM annealed circles, and 100 nM phi29 DNAP (purified in-house). The solution was mixed and immediately injected into the flow cell and incubated at 30 °C for 20 min. For digoxigenin incorporation as an end label, 100 μM dTTP was included in a 5, 50, or 500 molar excess over digoxigenin-11-ddUTP (Roche). ssDNA synthesis was quenched by removing excess nucleotides and polymerase with BSA buffer (40 mM Tris-HCl pH 8.0,2 mM MgCl2, 1 mM DTT, and 0.2 mg mL−1 BSA).
+ Open protocol
+ Expand
5

Droplet-based Multiple Displacement Amplification

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA was carried on in merged droplets, which were produced by a one-to-a-cluster merging strategy (Fig. 2a) with two series of droplets containing different MDA components. The small droplets contained 2× phi29 DNA polymerase reaction buffer (New England Biolabs Inc., MA, USA), 100 pg μL−1 λDNA solution (Takara Bio Inc., Shiga, Japan), 50 μM random hexamer primer, 4× SYBR Green (Life Technologies Inc., USA) and nuclease-free water. All these reagents were mixed and incubated for 3 min at 95 °C and then transferred onto ice before being encapsulated into 25 μm droplets. Large droplets were generated using a mixture of 8 mM dNTP (Takara Bio Inc., Shiga, Japan), 2× BSA solution, 2 U μL−1 phi29 DNA polymerase (New England Biolabs Inc., MA, USA) and nuclease-free water as the aqueous phase. The two series of droplets were merged as the one-to-a-cluster merging method. The velocity ratio of droplets was set to 1.0 and the final volume of each merged droplet was ∼150 pL. The merged droplets were collected and then incubated for 16 h at 30 °C.
+ Open protocol
+ Expand
6

Selective Whole Genome Amplification for Contamination Minimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selective whole genome amplification (SWGA) was performed according to published protocols27 (link). All SWGA reactions were carried out in the UV Cabinet for PCR Operations (UV-B-AR, Grant-Bio) to minimize contamination. SWGA reactions were performed containing a maximum of 50 ng of total input genomic DNA (and a minimum of 5 ng), 5 µl of 10 x Phi29 DNA Polymerase Reaction Buffer (New England BioLabs), 0.5 µl of Purified 100x BSA (New England BioLabs), 0.5 µl of 250 µM Primer mix of Pkset1, 5 µl 10 mM dNTP (Roche), 30 units Phi29 DNA Polymerase (New England BioLabs) and Nuclease-Free Water (Ambion, The RNA Company) to reach a final reaction volume of 50 µl. The reaction was carried out on a thermocycler with the following step-down program: 5 minutes at 35 °C, 10 minutes at 34 °C, 15 minutes at 33 °C, 20 minutes at 32 °C, 25 min 31 °C, 16 hours at 30 °C and 10 minutes at 65 °C. The SWGA samples were diluted 1:1 with EB buffer (Qiagen) and the reaction was purified using the AMPure XP beads (Beckman-Coulter), using a sample to beads ratio of 1:1 according to the protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!